XRME:XETRA:XETRA-Xtrackers MSCI USA ESG Screened UCITS ETF 2C EUR Hedged (EUR)

ETF | Others |

Last Closing

USD 10.884

Change

0.00 (0.00)%

Market Cap

N/A

Volume

426.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.53 (-1.00%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.19 (-1.12%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.27 (-0.96%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.28 (-0.96%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.74 (-2.86%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.25 (-0.54%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

-1.76 (-1.21%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.60 (-1.14%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-1.74 (-1.62%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-12.70 (-2.06%)

USD 80.38B

ETFs Containing XRME:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.13% 62% D 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.13% 62% D 59% D-
Trailing 12 Months  
Capital Gain 25.10% 81% B- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.10% 80% B- 79% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 13.79% 77% C+ 75% C
Dividend Return 13.79% 77% C+ 74% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.11% 48% F 57% F
Risk Adjusted Return 105.23% 91% A- 92% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.